%0 Journal Article
%T Safety and efficacy of obinutuzumab in Chinese patients with B-cell lymphomas: a secondary analysis of the GERSHWIN trial
%A Jun Zhu
%A Wanling Hsu
%A Wei Ji
%A Xin Du
%A Yan Qin
%A Yuankai Shi
%A Yuqin Song
%A Zhixiang Shen
%J Archive of "Cancer Communications".
%D 2018
%R 10.1186/s40880-018-0300-5
%X The online version of this article (10.1186/s40880-018-0300-5) contains supplementary material, which is available to authorized users
%K Obinutuzumab
%K B-cell lymphoma
%K Chronic lymphocytic leukemia
%K Chinese patients
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993131/